fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
fluoxetin viatris 20 mg
viatris limited - fluoksetinhydroklorid - kapsel, hard - 20 mg
fluoxetin sandoz 20 mg
sandoz - københavn - fluoksetinhydroklorid - dispergerbar tablett - 20 mg
fluoxetine orion 20 mg
orion corporation - espoo - fluoksetinhydroklorid - kapsel, hard - 20 mg
fluoxetine vitabalans 20 mg
vitabalans oy - fluoksetinhydroklorid - tablett, filmdrasjert - 20 mg
fontex 20 mg
eli lilly norge as - fluoksetinhydroklorid - dispergerbar tablett - 20 mg
fontex 20 mg
2care4 aps - fluoksetinhydroklorid - dispergerbar tablett - 20 mg
mirataz
dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - katter - for kroppsvekt få i katter opplever dårlig appetitt og vekttap som følge av kroniske medisinske tilstander.
metycor 250 mg
hra pharma rare diseases - metyrapon - kapsel, myk - 250 mg
ariclaim
eli lilly nederland b.v. - duloksetin - diabetiske neuropatier - psychoanaleptics, - behandling av diabetisk perifer neuropatisk smerte. ariclaim er indisert hos voksne.